Provided by Tiger Fintech (Singapore) Pte. Ltd.

Johnson & Johnson

154.88
+0.30000.19%
Volume:2.04M
Turnover:316.35M
Market Cap:372.65B
PE:17.24
High:155.81
Open:155.41
Low:153.83
Close:154.58
Loading ...

Market Chatter: Drugmakers Urge Trump to Phase in Pharma Tariffs Slowly

MT Newswires Live
·
01 Apr

Pre-Bell|U.S. Futures Slip; Tesla Gains 1%; XPeng Jumps 3%; PVH Surges 16%; Newsmax Soars Another 30%

Tiger Newspress
·
01 Apr

Johnson & Johnson To Reverse $7 Billion of Talc Reserve -- Market Talk

Dow Jones
·
01 Apr

J&J stock drops after failed attempt to end talc claims

Investing.com
·
01 Apr

Texas Bankruptcy Court denies Johnson & Johnson request to end cancer claims

TIPRANKS
·
01 Apr

Exclusive-Drugmakers Pressing Trump Administration for Phased Tariffs to Mitigate Impact of 25% Charge -Sources Say

THOMSON REUTERS
·
01 Apr

Exclusive-Drugmakers Do Not Expect Industry Specific Tariffs on Pharmaceuticals to Be Announced on Wednesday -Sources Say

THOMSON REUTERS
·
01 Apr

BUZZ-J&J falls after US judge rejects $10 bln baby powder settlement

Reuters
·
01 Apr

Johnson & Johnson Shares Down 2.3% Premarket After US Judge Rejects Co's $10 Bln Bid to Settle Talc Cancer Claims

THOMSON REUTERS
·
01 Apr

Johnson & Johnson Faces Setback as Bankruptcy Court Denies Talc Settlement Plan

MT Newswires Live
·
01 Apr

PRESS DIGEST- New York Times business news - April 1

Reuters
·
01 Apr

BRIEF-J&J Says Will Return To Tort System To Litigate Talc Claims

Reuters
·
01 Apr

J&J - Will Return to Tort System to Litigate Talc Claims

THOMSON REUTERS
·
01 Apr

Johnson & Johnson - to Reverse $7 Billion From Bankruptcy Reserve

THOMSON REUTERS
·
01 Apr

Johnson & Johnson to Return to Tort System to Defeat Meritless Talc Claims

Business Wire
·
01 Apr

Johnson & Johnson's Third Bankruptcy Case for Talc Lawsuits Thrown Out -- WSJ

Dow Jones
·
01 Apr

FACTBOX-Trump's tariffs and threatened trade actions

Reuters
·
01 Apr

JNJ's Rybrevant-Lazcluze Combo Outshines AZN's Tagrisso in Lung Cancer

Zacks
·
31 Mar

Pharma Stocks Sink After Ouster of Top FDA Vaccine Regulator

Reuters
·
31 Mar

1 Healthcare Stock to Target This Week and 2 to Turn Down

StockStory
·
31 Mar